Literature DB >> 29922928

LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.

Ji Soo Song1,2,3, Eun Jung Choi4,5,6, Seung Bae Hwang4,5,6, Hong Pil Hwang7, HyeMi Choi8.   

Abstract

OBJECTIVES: To use Liver Imaging Reporting and Data System (LI-RADS) categorization and features of hepatocellular carcinomas (HCCs) to intraindividually compare gadopentetate dimeglumine-enhanced magnetic resonance imaging (Gd-DTPA-MRI) and gadoxetic acid-enhanced MRI (Gd-EOB-MRI), before and after applying modified major features.
METHODS: Of 77 HCCs in 64 patients analysed, 17 HCCs were confirmed histopathologically and 46 patients had cirrhosis. Gd-EOB-MRI and Gd-DTPA-MRI were evaluated for the presence of major and ancillary features by two radiologists. LI-RADS categorization was done for Gd-DTPA-MRI (LI-RADS-DTPA) and for Gd-EOB-MRI before and after applying modified major features (hepatobiliary phase [HBP] hypointensity as an additional major feature, LI-RADS-EOBm1; HBP hypointense rim as capsule appearance, LI-RADS-EOBm2; and transitional phase [TP] hypointensity as washout appearance, LI-RADS-EOBm3). Sensitivities of LR-5 categorization for the diagnosis of HCC were compared.
RESULTS: Washout (p=0.012) and capsule appearance (p<0.001) were less frequently observed on Gd-EOB-MRI. Sensitivity for LR-5 categorization was significantly higher with LI-RADS-DTPA compared with LI-RADS-EOB (p=0.001) and LI-RADS-EOBm2 (p=0.004), while sensitivity for LR-5 categorization with LI-RADS-EOBm1 (p=0.210) and LI-RADS-EOBm3 (p=0.727) was comparable.
CONCLUSION: Modifying LI-RADS for use with Gd-EOB-MRI, such as applying HBP hypointensity as an additional major feature or using TP hypointensity as washout appearance, can improve the sensitivity for the detection of HCC. KEY POINTS: • Adding HBP hypointensity as additional major feature improved sensitivity of LR-5 categorization. • Adding TP hypointensity as modified washout appearance improved sensitivity of LR-5 categorization. • Sensitivities for LR-5 classification were comparable between LI-RADS-DTPA, LI-RADS-EOBm1, and LI-RADS-EOBm3.

Entities:  

Keywords:  Diagnosis; Gadopentetate dimeglumine; Hepatocellular carcinoma; Liver; Magnetic resonance imaging

Mesh:

Substances:

Year:  2018        PMID: 29922928     DOI: 10.1007/s00330-018-5559-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.

Authors:  Sang Hyun Choi; Jae Ho Byun; Young-Suk Lim; Eunsil Yu; So Jung Lee; So Yeon Kim; Hyung Jin Won; Yong Moon Shin; Pyo Nyun Kim
Journal:  J Hepatol       Date:  2016-01-25       Impact factor: 25.083

Review 2.  Hepatobiliary agents and their role in LI-RADS.

Authors:  Thomas A Hope; Kathryn J Fowler; Claude B Sirlin; Eduardo A C Costa; Judy Yee; Benjamin M Yeh; Jay P Heiken
Journal:  Abdom Imaging       Date:  2015-03

3.  Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.

Authors:  Chansik An; Hyungjin Rhee; Kyunghwa Han; Jin-Young Choi; Young-Nyun Park; Mi-Suk Park; Myeong-Jin Kim; Sumi Park
Journal:  Eur Radiol       Date:  2016-10-21       Impact factor: 5.315

Review 4.  Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai
Journal:  Oncology       Date:  2014-11-22       Impact factor: 2.935

Review 5.  2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.

Authors:  Jeong Min Lee; Joong-Won Park; Byung Ihn Choi
Journal:  Dig Dis       Date:  2014-10-29       Impact factor: 2.404

Review 6.  Review article: the reversibility of cirrhosis.

Authors:  A A Sohrabpour; M Mohamadnejad; R Malekzadeh
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

7.  Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Tomoaki Ichikawa; Kazuhiro Saito; Naoki Yoshioka; Akihiro Tanimoto; Takehiko Gokan; Yasuo Takehara; Takeshi Kamura; Toshifumi Gabata; Takamichi Murakami; Katsuyoshi Ito; Shinji Hirohashi; Akihiro Nishie; Yoko Saito; Hiroaki Onaya; Ryohei Kuwatsuru; Atsuko Morimoto; Koji Ueda; Masayo Kurauchi; Josy Breuer
Journal:  Invest Radiol       Date:  2010-03       Impact factor: 6.016

8.  Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.

Authors:  Sang Hyun Choi; Jae Ho Byun; So Yeon Kim; So Jung Lee; Hyung Jin Won; Yong Moon Shin; Pyo Nyun Kim
Journal:  Invest Radiol       Date:  2016-08       Impact factor: 6.016

9.  Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.

Authors:  A Granito; M Galassi; F Piscaglia; L Romanini; V Lucidi; M Renzulli; A Borghi; L Grazioli; R Golfieri; L Bolondi
Journal:  Aliment Pharmacol Ther       Date:  2012-12-02       Impact factor: 8.171

Review 10.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

View more
  5 in total

1.  LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?

Authors:  Roberto Cannella; Federica Vernuccio; Michela Antonucci; Domenico Salvatore Gagliano; Francesco Matteini; Massimo Midiri; Giuseppe Brancatelli
Journal:  Eur Radiol       Date:  2021-09-20       Impact factor: 7.034

2.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

3.  Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma.

Authors:  Yueming Li; Jianwei Chen; Shuping Weng; Chuan Yan; Rongping Ye; Yuemin Zhu; Liting Wen; Dairong Cao; Jinsheng Hong
Journal:  Ann Transl Med       Date:  2021-01

4.  Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis.

Authors:  Xi Zhong; Hongsheng Tang; Tianpei Guan; Bingui Lu; Chuangjia Zhang; Danlei Tang; Jiansheng Li; Shuzhong Cui
Journal:  J Clin Transl Hepatol       Date:  2021-05-28

Review 5.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.